Cutler Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $112K | Sell |
3,899
-10,304
| -73% | -$296K | 0.04% | 250 |
|
|
2023
Q4 | $466K | Buy |
14,203
+13,099
| +1,187% | +$430K | 0.04% | 255 |
|
|
2023
Q3 | $30K | Sell |
1,104
-46
| -4% | -$1.25K | ﹤0.01% | 793 |
|
|
2023
Q2 | $39K | Buy |
+1,150
| New | +$39K | 0.01% | 669 |
|
|
2023
Q1 | – | Sell |
-11,428
| Closed | -$322K | – | 1438 |
|
|
2022
Q4 | $322K | Buy |
11,428
+90
| +0.8% | +$2.54K | 0.03% | 344 |
|
|
2022
Q3 | $372K | Buy |
11,338
+4,879
| +76% | +$160K | 0.03% | 334 |
|
|
2022
Q2 | $203K | Sell |
6,459
-9,061
| -58% | -$285K | 0.01% | 460 |
|
|
2022
Q1 | $712K | Buy |
15,520
+11,920
| +331% | +$547K | 0.04% | 289 |
|
|
2021
Q4 | $220K | Buy |
3,600
+1,800
| +100% | +$110K | 0.01% | 651 |
|
|
2021
Q3 | $134K | Buy |
1,800
+407
| +29% | +$30.3K | 0.01% | 840 |
|
|
2021
Q2 | $128K | Sell |
1,393
-407
| -23% | -$37.4K | 0.01% | 889 |
|
|
2021
Q1 | $159K | Sell |
1,800
-3,496
| -66% | -$309K | 0.01% | 743 |
|
|
2020
Q4 | $493K | Buy |
5,296
+492
| +10% | +$45.8K | 0.02% | 354 |
|
|
2020
Q3 | $306K | Buy |
+4,804
| New | +$306K | 0.02% | 391 |
|